Sloane Robinson

Sloane Robinson Investment Services Limited is a privately owned hedge fund sponsor based in London, established in 1993. The firm specializes in investing in public equity markets worldwide, utilizing a blend of top-down and bottom-up stock picking strategies to develop its investment portfolios. Formerly known as Sloane Robinson Investment Management Limited, the firm has maintained a focus on global equity investments throughout its history.

George Robinson

Partner

2 past transactions

Videojug

Series B in 2007
Videojug is a leader in short-form digital entertainment, specializing in the creation and distribution of video content since its inception in 2006. The company provides a wide range of video production services tailored to meet various creative needs, including branded entertainment, corporate communications, training videos, and live event coverage. With a library of over 60,000 films, Videojug leverages its extensive experience in commercial production to deliver engaging and effective content. Its platform empowers users to learn new skills or discover useful tips through online social videos, ultimately aiming to maximize viewer engagement and achieve optimal results for brands and consumers alike.

Orthomimetics

Series A in 2006
Orthomimetics was founded in 2005 as a spin-out from the University of Cambridge and the Massachusetts Institute of Technology (MIT). Its products are based on a leading collagen biomaterials platform for the production of scaffolds for cartilage, meniscus, ligament and tendon repair. Orthomimetics’ flagship product, Chondromimetic™, is an off-the-shelf, resorbable implant for the minimally invasive repair of small osteochondral (cartilage and underlying bone) defects. The product has received European market approval (CE-Mark approval) and is close to entering the European market. Small osteochondral defects represent an important medical need that is currently not covered by TiGenix’ products. Chondromimetic™ forms an excellent fit with TiGenix’ lead product, ChondroCelect®, since both products target the same customer base in complementary indications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.